Healthcare
Discover news, funding updates, regulatory changes, and sector insights impacting the health care industry in India.
Healthcare
Is Piramal Healthcare Now Shedding Diagnostics Biz?
The sellout story in the Indian healthcare industry continues. Piramal Healthcare, the flagship company owned by Ajay Piramal, is believed ......
Healthcare
Jubilant Organosys To Demerge Pharma Business
Jubilant Organosys Ltd is the latest to join the bandwagon of firms planning to amalgamate and de-merge the entire pharma ......
Healthcare
Khazanah To Extend $835M Parkway Offer
Malaysian state investor Khazanah, which has bid $835 million to double its stake in Singapore hospital operator Parkway Holdings, will ......
Healthcare
Fortis Revokes 39M Pledged Shares
Fortis Healthcare, locked in a battle to take control of Singapore's Parkway Holdings, said on Monday the owners of the ......
Healthcare
Care Hospitals On Fund Trail; Jhunjhunwala, Prasad May Sell Stake
Care Hospitals, a South India-based healthcare chain, is looking to raise around Rs 200 crore in a deal which could ......
Healthcare
Henderson Cuts Stake In Jubilant Organosys
Henderson Equity Partners has made a partial exit from its five-and-half-year-old investment in drug and chemical makers Jubilant Organosys. The ......
Healthcare
Fortis May Become A Subsidiary Of Parkway Holdings
Brothers Malvinder and Shivinder Singh plan to make Fortis Healthcare a subsidiary of Parkways once the company successfully acquires Singapore-based ......
Healthcare
Fortis Makes Counter Offer At SGD 3.78/Share For Parkway
Fortis Healthcare Ltd, which is in battle with Khazanah Nasional Bhd to acquire Singapore-based Parkway Holdings Ltd, made a counter ......
Healthcare
A Lukewarm Listing Debut For BTS India-Backed Parabolic Drugs
BTS India Private Equity-backed pharmaceutical firm Parabolic Drugs has made a disappointing debut on the stock exchange. Although the scrip ......
Healthcare
Pharma Firms Demerging Domestic Biz; Eyeing Better Valuation
With multinational pharma companies scouring for deals to tap the Rs 41,000-crore Indian pharma market, domestic firms are actively exploring ......
